The independent source for health policy research, polling, and news.
29,181 - 29,200 of 112,425 Results
Pharmaceutical companies traditionally have been restricted from distributing information about off-label uses to doctors, which they say is a violation of free speech. Critics, however, are worried that more freedom for the drugmakers could jeopardize patient safety.
More details are emerging over what the drug company paid to try to gain insight into President Donald Trump's health strategy. CEO Vasant Narasimhan wrote to employees that he understood they felt "disappointed and frustrated."
Democrats say the Trump administration's proposal to extend short-term plans will weaken the marketplace by allowing healthy people to buy coverage that's not compliant with the health law. But HHS Secretary Alex Azar says it's just returning to a status quo that only changed in 2017. Meanwhile, President Donald Trump hints the White House has some "great health plans" coming out in the next few weeks, but didn't go into details.
President Donald Trump is expected to focus on pharmacy benefit managers, foreign governments and generic drugs in his speech today. He's reportedly backed away from a campaign talking point on allowing Medicare to negotiate lower drug prices. Critics have been quick to point out that the proposals will do little to rock the pharma industry, which Trump once claimed was "getting away with murder."
Today's early morning highlights from the major news organizations.
Editorial writers focus on these and other health topics.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
Media outlets report on news from Missouri, New Hampshire, Florida, Louisiana, Connecticut, Virginia, Arizona, Tennessee, Minnesota, Texas, Massachusetts, California, Puerto Rico and Colorado.
Florida, Minnesota, North Dakota and Texas are among the 29 states reporting at least one case, but it's unclear if new illnesses are still occurring because there's a lag time in the reporting.
Researchers have recovered DNA from the oldest viruses known to have infected humans. The discovery may provide clues to the continuing evolution of hepatitis B, a disease that infects an estimated 257 million people worldwide. In other public health news: breast-feeding, medical devices, pregnancy and labor, assisted suicide, and Ebola.
Tobacco residue can cling to surfaces and then move around the room. Research on the health effects of third-hand smoke suggests it could be harmful, but data remains scarce and mostly limited to studies involving mice.
The current policy requires the Red Cross and other blood suppliers to test each donation they receive individually, which accounts for the high cost, and the blood system operators would like to be able to dial back that screening.
Gabapentin was involved in more than a third of Kentucky overdose deaths last year. The pills enhance the euphoric effects of heroin and when taken alone in high doses can produce a marijuana-like high. In other news on the crisis: the judge overseeing a massive combined lawsuit against drugmakers plans to hold a brief open-court session; the House Energy and Commerce Committee on Wednesday approved 25 opioid-related bills; and more.
Those who could be affected by the Medicaid cuts include about 19,000 people who live in nursing homes. Meanwhile, a proposed federal bill would allow the government to fine drugmakers for providing incorrect information to Medicaid.
The findings shine a light on the back-end negotiations and contracts between dominant hospitals and insurers. Meanwhile, HHS Secretary Alex Azar promises to make value-based care models easier to sustain, and an alliance is trying to combat the trend of hospitals buying up doctors' practices.
The lawsuit says that HIV patients suffered from as many as 10 years of "additional accumulated kidney and bone toxicity" while using the drug tenofovir as the company kept the less-toxic version on a shelf in its lab.
The lawsuits target Stem Cell Treatment Center, with two locations in Southern California, and U.S. Stem Cell Clinic of Sunrise, Fla. The clinics remove fat from patients’ bellies by liposuction and then inject an extract of it into various parts of the body like knees or the spinal cord.
According to an insider, though, the pharmaceutical company was disappointed with what Michael Cohen could offer. Cohen's business activities have been under investigation by both special counsel Robert Mueller and the U.S. attorney for the Southern District of New York.
President Donald Trump is also expected to go after pharmacy benefit managers, saying PBMs profit from rebates paid by drug companies but do not share much of the savings with patients. The twice-delayed speech is now scheduled for Friday.
Today's early morning highlights from the major news organizations.
© 2026 KFF